Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013-2018

• Prif Awduron: Arun Kumar (Awdur), Pamela L. Lutsey (Awdur), Wendy L. St. Peter (Awdur), Jon C. Schommer (Awdur), Jeremy R. Van't Hof (Awdur), Abhijeet Rajpurohit (Awdur), Joel F. Farley (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Wiley, 2023-10-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract P2Y12 inhibitors (i.e., clopidogrel, prasugrel, or ticagrelor) are effective at reducing adverse cardiovascular outcomes post‐revascularization in coronary artery disease (CAD). However, the choice of a specific P2Y12 inhibitor may vary according to the patient's characteristics, and t...